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Background: α-Amylases catalyze the hydrolysis of α-D-(1,4)-glucan linkages
in starch and related compounds. There is a wide range of industrial and
medical applications for these enzymes and their inhibitors. The Ragi
bifunctional α-amylase/trypsin inhibitor (RBI) is the prototype of the cereal
inhibitor superfamily and is the only member of this family that inhibits both
trypsin and α-amylases. The mode of inhibition of α-amylases by these cereal
inhibitors has so far been unknown.
Results:  The crystal structure of yellow meal worm α-amylase (TMA) in
complex with RBI was determined at 2.5 Å resolution. RBI almost completely
fills the substrate-binding site of TMA. Specifically, the free N terminus and the
first residue (Ser1) of RBI interact with all three acidic residues of the active site
of TMA (Asp185, Glu222 and Asp287). The complex is further stabilized by
extensive interactions between the enzyme and inhibitor. Although there is no
significant structural reorientation in TMA upon inhibitor binding, the N-terminal
segment of RBI, which is highly flexible in the free inhibitor, adopts a 310-helical
conformation in the complex. RBI’s trypsin-binding loop is located opposite the
α-amylase-binding site, allowing simultaneous binding of α-amylase and trypsin.
Conclusions: The binding of RBI to TMA constitutes a new inhibition
mechanism for α-amylases and should be general for all α-amylase inhibitors of
the cereal inhibitor superfamily. Because RBI inhibits two important digestive
enzymes of animals, it constitutes an efficient plant defense protein and may be
used to protect crop plants from predatory insects.
Introduction
α-Amylases (α-1,4-glucan-4-glucanohydrolase, EC 3.2.1.1)
catalyze the hydrolysis of α-D-(1,4)-glucan linkages in
starch components, glycogen and various other related car-
bohydrates. They constitute a widely distributed family of
enzymes found in micro-organisms, plants and animals,
and are central in carbohydrate metabolism. Insect and
mammalian α-amylases show a high degree of homology
in their primary [1] and tertiary structures [2]. Neverthe-
less, several inhibitors of insect α-amylases were reported
to inhibit pig pancreatic α-amylase (PPA) and other mam-
malian α-amylases only with low affinity or not at all
[3–10]. The structural basis for inhibition of α-amylases by
the widely occurring natural inhibitors is in most cases
unknown. Until now, almost all structural studies on the
interaction of α-amylases with substrate analogs [11,12],
carbohydrate inhibitors [13,14] and proteinaceous inhibitors
[15,16] have been performed with PPA. We have recently
determined the first three-dimensional structure of an
α-amylase from insects, namely the α-amylase (TMA)
from the yellow meal worm (larvae of Tenebrio molitor) to
1.64 Å resolution by X-ray crystallography [2]. TMA is a
monomeric protein of 471 residues that consists of three
domains (A–C). The enzyme contains four disulfide bridges,
a structural calcium ion and a chloride ion, which allosteri-
cally activates the enzyme. The long substrate-binding cleft
of TMA may accommodate six saccharide units, with sub-
strate hydrolysis taking place between the third and fourth
pyranose [2,14]. Asp185, Glu222 and Asp287 are supposed
to be key residues for catalysis [2]. TMA’s polypeptide fold
resembles that of PPA, but there are important differences
in loop segments next to the active-site region [2]. Because
TMA is the only insect α-amylase for which a three-dimen-
sional structure is available, it constitutes the model enz-
yme for structural studies on the specific inhibition of insect
α-amylases.
The bifunctional α-amylase/trypsin inhibitor (RBI) from
Ragi (Eleusine coracana Gaertn.; Indian finger millet) is the
prototype of the cereal inhibitor superfamily and is the only
member of this family for which independent inhibitory
activities against both trypsin and α-amylases have been
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reported [17]. Like other inhibitors of this family, RBI
inhibits α-amylases from various sources. The proteins’
exact mode of α-amylase inhibition was so far unknown,
however. RBI is a monomer of 122 amino acids with five
disulfide bonds. The three-dimensional structure of recom-
binant RBI in solution was solved by nuclear magnetic reso-
nance (NMR) spectroscopy. The globular fold of RBI
consists of four α helices with simple ‘up-and-down’ topo-
logy and a small antiparallel β sheet [18]. The trypsin-bind-
ing loop of RBI adopts the ‘canonical’, substrate-like
conformation, which is highly similar among completely
unrelated serine proteinase inhibitor families [19]. The
existence of a ternary complex between trypsin, RBI and
α-amylase suggested that RBI’s α-amylase-binding site is
located opposite the trypsin-binding loop [17]. But neither
the known structures of RBI and various α-amylases, nor a
comparison of the primary structures of RBI and other
α-amylase inhibitors from the cereal inhibitor superfamily,
gave hints on the exact location of RBI’s α-amylase-binding
site [18].
Here, we describe the three-dimensional structure of the
complex between RBI and TMA at 2.5 Å resolution. It
reveals a completely new inhibition mode for proteina-
ceous α-amylase inhibitors. The N-terminal residues of
RBI, which are unstructured in solution, fold into a helical
conformation upon binding to the enzyme, whereas the
free N terminus directly targets the catalytic residues of
the α-amylase.
Results and discussion
Structure of the complex
In the RBI–TMA complex the inhibitor binds to the
active site of the enzyme, which lies in a V-shaped depres-
sion at the interface of the domains A and B (Figure 1).
This is in agreement with biochemical experiments,
which proved a competitive inhibition mode for the inter-
action between RBI and the porcine enzyme, PPA [17].
RBI exclusively interacts with residues from domains A
and B of TMA, which wall the substrate-binding site.
Altogether, 26 residues of the inhibitor interact with 28
residues of the enzyme. The contacts are summarized in
Table 1. The overall contact area between enzyme and
inhibitor is 1201 Å2.
The substrate-binding cleft of TMA, like that of PPA,
provides at least six subsites for binding of carbohydrate
moieties, as the pseudo-hexasaccharide inhibitor V-1532
(a member of the trestatin family) can easily be modeled
into the cleft of TMA on the basis of the X-ray structure of
the PPA–V-1532 complex [14]. In the RBI–TMA complex,
the analogous subsites 1–5 in TMA are completely blocked
by residues of RBI (Figures 2 and 3). In particular, two
functional segments can be identified in RBI that interact
with the α-amylase in a very specific manner (Figure 3).
Segment 1, comprising the N-terminal residues Ser1–Ala11
and residues Pro52–Cys55, protrudes like an arrow head
into TMA’s substrate-binding groove and directly targets
the active site of the enzyme. The five N-terminal RBI
residues form the tip of the arrow. Although residues 1–5
are flexible in the solution structure of free RBI, they
adopt a 310-helical conformation in the complex with TMA
and fill the saccharide-binding subsites 3 (Ser1), 2 (Val2),
and 4 (Thr4). Ile7 and Met10 sterically block the access to
subsite 5 (Figure 3). Ser1 is involved in numerous hydro-
gen bonds with residues in the active site of TMA (Table 1,
Figure 4). The N-terminal amino group of Ser1 interacts
with the carboxyl groups of two catalytic residues in TMA,
Asp185 Oδ1 and Glu222 Oε1 and Oε2. The hydroxyl group
of Ser1 forms hydrogen bonds to the third catalytic residue
Asp287 (Oδ2), to TMA’s chloride-binding residue Arg183
(Nη2) and to His286 Nε2, which is invariant in the active
sites of α-amylases. The carbonyl oxygen atom of Ser1 inter-
acts via water-mediated hydrogen bonds with the catalytic
residue Asp185 (Oδ2) and with Nε2 of His99, which is
also absolutely conserved in α-amylases. Thus, Ser1 com-
pletely fills the sugar-binding subsite 3 of the enzyme. In
addition, Val2 N and Ser5 Oγ of RBI interact by direct
and water-mediated hydrogen bonds, respectively, with
the carboxyl group of the third catalytic residue of TMA,
Asp287. Hydrophobic interactions between Val2 (RBI) and
Trp56, Trp57 and Tyr60 of TMA, which cover the saccha-
ride-binding subsites 2 and 3, additionally position Val2
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Figure 1
A ribbon diagram of the RBI–TMA complex. RBI is shown in gold. The
three TMA domains, A (residues 1–97 and 160–379), B (residues
98–159) and C (residues 380–471), are depicted in blue, green and
red, respectively. Disulfide bridges in RBI and TMA are shown in red
and yellow, respectively. This figure was made with SETOR [37].
(RBI) at subsite 2. Tyr54 (RBI) lies like a lid above Val2
(RBI) and stabilizes its conformation via hydrophobic inter-
actions, while also interacting with the TMA residues Trp56
and Trp57.
The binding segment 2 of RBI comprising residues Arg61,
Val67–Ser70, Gly72, Thr107–Gly110 and Leu115–Leu117
lies like a collar around the upper part of the arrow head
formed by segment 1. This ‘collar’ extends from sugar
subsite 1 to a position slightly above sugar-binding subsite
6 (Figure 3) and stabilizes the complex by mainly interact-
ing with TMA residues from domain B. Segment 2 inter-
acts with residues from domain A of TMA at the contact
area most distant from the active site of TMA. Ile108 fills
sugar-binding subsite 1. Access of substrate may also be
prevented by steric hindrance conferred by the C-terminal
residues 118–122 of RBI, for which no density was found
in the electron density map.
A comparison of the molecular models of free TMA and
TMA complexed with RBI
No major structural differences can be detected between
the models of free TMA [2] and TMA complexed with RBI.
Both structures superimpose with root mean square devia-
tions (rmsd) of 0.4 Å for the backbone atoms and 0.6 Å
for all non-hydrogen atoms. Despite extensive interactions
with the inhibitor, the sidechains of residues in the active
site undergo only minor rearrangements upon binding of
RBI. The strongest deviation from the unliganded confor-
mation is observed for the Oδ2 of the catalytic sidechain of
Asp287. Our results suggest that this atom moves 0.8 Å
upon binding RBI, whereas Cβ and Oδ1 remain at their
positions. The Ramachandran plots [20] of the (φ/ψ) angles
demonstrate that the TMA residues in both structures have
very similar mainchain angles [2]. This is also true for
Asp390, which is in the generously allowed region in the
structure of free TMA and in the disallowed region in the
complex structure (see the Material and methods section).
Moreover, the solvent structure in the central part of the
active site of TMA is completely different in free TMA
and the RBI–TMA complex because the inhibitor dis-
places the water molecules around the catalytic site. An
exception is the water molecule bridging the carbonyl
groups of Glu222 and Asp287 (Figure 4), which is found at
the same position in both structures. This water has previ-
ously been suggested to be the nucleophile attacking the
C1 atom of the pyranose ring in subsite 3 [21].
A comparison of the molecular models of free RBI in
solution and RBI complexed with TMA in the crystal
The RBI structure derived from the X-ray structure of the
RBI–TMA complex is quite similar to the solution struc-
ture of RBI [18], despite the diversity of the analytical
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Table 1
Contacts and hydrogen bonds between RBI and TMA.
Total contacts (distance < 4.0 Å) between RBI and TMA Hydrogen bonds between RBI and TMA
RBI TMA RBI TMA Domain Distance* (Å) Mediated by
Ser1 Tyr60, Arg183, Asp185, Ser1 N Glu222 Oε1 A 2.9
Glu222, His286, Asp287 Glu222 Oε2 A 3.1
Val2 Trp56, Trp57, Tyr60, Asp287 Asp185 Oδ1 A 2.6
Gly3 Leu150, Val151 Ser1 Oγ Arg183 Nη2 A 3.0
Thr4 Glu222, Ile224 His286 Nε2 A 3.0
Ser5 Thr291 Asp287 Oδ2 A 2.6
Cys6 Val151 Ser1 O His99 Nε2 B wat 1005
Ile7 Tyr139 Asp185 Oδ2 A wat 1005
Met10, Ala11 Thr291 Val2 N Asp287 Oδ1 A 3.0
Pro52, Ala53 Asp332 Ser5 Oγ Asp287 Oδ1 A wat 1004
Tyr54 Trp56, Trp57, Thr291, Ala53 N Asp332 Oδ2 A 2.8
Asn331, Asp332 Tyr54 Oη Asp287 Oδ1 A wat 1004
Arg61 Glu135, Val136, Asn137 Glu58 Oε1 Val136 O B wat 1148
Asp65 Glu135 Val68 N N137 O B 3.0
Val67 Asn137 Val68 O Tyr139 N B 3.0
Val68 Asn137, Asn138, Tyr139, Gln140 Thr69 O Gln140 Nε2 B 2.8
Thr69, Gly72 Gln140 Ser70 Oγ Glu229 Oε2 A wat 1023
Ser70 Gln140, Gly227, Gly228, Glu229 His109 Nδ1 Gly102 O B 2.7
Thr107 Trp57 Ser116 O Glu135 Oε1 B wat 1146
Ile108 Trp57, Gln61, Met103, Val151
His109 Gly102, Met103
Gly110 Asp52, Met103
Leu115 Gly102
Ser116 Glu135, Gly152
Leu117 Glu135
*Heavy atom distances. wat, water molecules.
techniques used. RBI residues 6–114 superimpose with
rmsds of 2.0 Å for the backbone atoms and 2.8 Å for all
non-hydrogen atoms (Figure 5). Differences are found
mainly in regions that contribute to α-amylase binding or
are directly adjacent to the hydrolase-binding site (residues
1–11 in α-amylase binding segment 1, and residues 68–71,
101, 105–110, 112 and 114 in or next to binding segment 2;
the rmsd for non-hydrogen atoms in these regions is
> 2.0 Å), as well as in regions involved in crystal contacts
(residues 18, 28, 29 and 34; the rmsd for non-hydrogen
atoms is > 2.0 Å).
The relative positions of the regular secondary structures
of RBI in the complex are the same in the NMR structure
of free RBI, except that helices 3 and 4 are extended and
residues 2–5 form an additional 310 helix in the complex.
The N-terminal and C-terminal RBI segments 1–5 and
118–122 were found to be unstructured in the solution
structure of RBI. In the X-ray structure of the enzyme–
inhibitor complex, the N-terminal RBI segment is well
structured and forms a 310 helix (Val2–Ser5; H0 in Figure 6),
which is clearly induced by binding to the enzyme. No
electron density was observed for the C-terminal five
residues of RBI (Leu118–Glu122) indicating that the
C terminus is also unstructured in the crystal. 
Helix 3 of RBI in the complex starts with two residues in
a 310-helical conformation and extends from position 53
to position 65 (58–65 in the NMR structure). Not all
NOEs diagnostic for a helical conformation were found
for residues 53–57 in the NMR spectra, and hydrogen-
exchange experiments showed that the backbone amide
protons of residues 55–62 are not protected from exchange
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Figure 3
A stereo view of the superposition of RBI (as
bound to TMA) and the carbohydrate inhibitor
V-1532 (as bound to PPA [14]; cf. legend of
Figure 2). The backbone atoms of RBI are
shown in green. RBI’s α-amylase-binding site
with selected sidechains is depicted in red
(segment 1) and blue (segment 2). The
carbohydrate units 1–6 of V-1532 are shown
in black. The trypsin-binding loop of RBI,
which is located at the opposite side of the
α-amylase-binding site, and the sidechains of
Arg34 and Leu35, which form the scissile
peptide bond, are shown in black. For
modeling, the same atoms as in Figure 2 were
initially superimposed; numbering is as in
Figure 2. This figure was made with
MOLMOL [39].
Figure 2
A close up of TMA’s active site. (a) A model of the complex between
TMA and the hexasaccharide inhibitor V-1532. The model was derived
after optimal superposition of free TMA [2] with PPA complexed with 
V-1532 [14] and removal of the PPA coordinates. The Cα atoms of the
following TMA and PPA residues were superimposed for the modeling:
2–51, 54–103, 117–132, 135–201, 217–256, 259–288, 299–328,
347–407 and 410–471 for TMA; and 2–51, 56–105, 123–138,
147–213, 228–267, 272–301, 314–343, 371–431 and 435–496 for
PPA. The electrostatic surface potential of TMA is shown (red for partial
negative charges, blue for partial positive charges) and the carbohydrate
moieties of V-1532 are numbered according to the substrate-binding
subsites of TMA that they are bound to. (b) The same view as in (a),
but with RBI residues 1–10, 53–55, and 107–109 displayed (the
sidechain of Pro8 is omitted). This figure was made with GRASP [38].
[18]. This indicates that residues 53–57 are actually not
in a strictly helical conformation in solution. We suggest
that the helix becomes longer upon complex formation
as a result of the interactions of residues 53–57 and adja-
cent RBI residues with TMA. The conformational switch
of the N-terminal segment 1–11 may also induce the
helical conformation of RBI segment 53–57 in the complex
via the disulfide bridge Cys6–Cys55.
Helix 4 of RBI comprises residues 87–97 in the structure of
the complex and is therefore three residues longer than in
the reported NMR structure of RBI (residues 87–94). In the
complex, Pro95 induces a helix kink and the two following
residues are in a 310-helical conformation. It is likely that
this segment is in the same conformation in the solution
structure of RBI because residues 97–99 of free RBI are pro-
tected from hydrogen exchange [18]. We could not identify
310-helical NOE signals, however, because of overlaps in the
NMR spectra (Lys96 and Leu97), nor could we assign the
Cα-proton of Pro95. Thus, the NMR data did not allow a
more accurate structural description of segment 95–97.
The comparison of the Ramachandran plots of the NMR
structure of RBI [18] and the structure of RBI in complex
with TMA reveals that Val2 and Met10 appear in the dis-
allowed region upon complex formation, whereas Cys6,
Ala11 and Ala106 disappear from this region (data not
shown). All these residues are part of RBI’s α-amylase
binding segments and undergo a structural reorientation
upon binding of TMA. 
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Figure 4
A stereo view of the electron density of TMA’s
catalytic residues Asp185, Glu222 and
Asp287 and RBI’s N-terminal residues Ser1
and Val2. The electron density was calculated
with coefficients (2Fobs – Fcalc) and contoured
at 1.0σ. This figure was made with
TURBO-FRODO [35].
Figure 5
A stereo view of the superposition of the
backbones of the energy-minimized mean
NMR structure of RBI (red) and the RBI
structure in the RBI–TMA complex (blue).
Disulfide bridges for RBI and for RBI in
complex with TMA are depicted in orange and
cyan, respectively. TMA is not shown. For the
superposition, the Cα atoms of residues
6–114 from both RBI models were used. This
figure was made with MOLMOL [39].
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Figure 6
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                                   xxx-x            ============...........=---==============  x-x======
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[40] Ragi bifunctional inhibitor  SVGT-SCIPGMAIPHNPLDSCRWYVSTRTCGV----GPRLAT---QEM-KARCCRQLEAIPA-YCRCEAV
Members known as trypsin inhibitors
[41] Maize TI (66 %)              SAGT-SCVPGWAIPHNPLPSCRWYVTSRTCGI----GPRLPW---PEL-KRRCCRELADIPA-YCRCTAL
[42] Rye TI (62 %)                SVGG-QCVPGLAMPHNPLGACRTYVVSQICHV----GPRLFT---WDM-KRRCCDELLAIPA-YCRCEAL
[43] Barley TI/CMe (56 %)       (S)FGD-SCAPGDALPHNPLRACRTYVVSQICHQ----GPRLLT---SDM-KRRCCDELSAIPA-YCRCEAL
α-Amylase inhibitors active as monomers or homodimers
[44] Sorghum AI SIalpha4 (43 %)   TVDVTACAPGLAIPAPPLPTCRTFARPRTCGLGGPYGPVDPS---PVL-KQRCCRELAAVPS-RCRCAAL
[44] Sorghum AI SIalpha5 (41 %)    ANW--CEPGLVIPLNPLPSCRTYMVRRACGVSI--GPVVPL---PVL-KERCCSELEKLVP-YCRCGAL
[45] Barley CMa (41 %)            TGQY--CYAGMGLPSNPLEGCREYVAQQTCGVTIA-GSPVSSEPGDTP-KDRCCQELDEAPQ-HCRCEAV
[46] Wheat AI 0.19 (26 %)         SGPW-MCYPGQAFQVPALPACRPLLRLQ-CN-----GSQV-----PEAVLRDCCQQLAHISE-WCRCGAL
[47] Wheat AI 0.28(26 %)          SGPWSWCNPATGYKVSALTGCRAMVKLQ-CV-----GSQV-----PEAVLRDCCQQLADINNEWCRCGDL
[48] Wheat AI 0.53 (25 %)         SGPW-MCYPGQAFQVPALPGCRPLLKLQ-CN-----GSQV-----PEAVLRDCCQQLADISE-WPRCGAL
α-Amylase inhibitors active as heterooligomers
[49] Barley CMd (43 %)               T-DCSPGVAFPTNLLGHCRDYVLQQTCAV-FTPGSKLP-X1-PYLAKLYCCQELAEIPQ-QCRCEAL
[50] Wheat CM2 (42 %)             TGPY--CYPGMGLPSNPLEGCREYVAQQTCGV-GIVGSPVSTEPGNTP-RDRCCKELYDASQ-HCRCEAV
[51] Wheat CM3 (41 %)             SASG-SCVPGVAFRTNLLPHCRDYVLQQTCGT-FTPGSKLP-X3-PYLAKLYCCQELAEISQ-QCRCEAL
[51] Wheat CM1 (41 %)             TGPY--CYAGMGLPINPLEGCREYVAQQTCGISIS-GSAVSTEPGNTP-RDRCCKELYDASQ-HCRCEAV
[45] Barley CMb (39 %)            VGSE-DCTPWTATPITPLPSCRDYVEQQACRI-ETPGP-------PYLAKQQCCGELANIPQ-QCRCQAL
[52] Wheat AI CM17 (37 %)         VGNE-DCTPWTSTLITPLPSCRNYVEEQACRI-EMPGP-------PYLAKQECCEQLANIPQ-QCRCQAL
[53] Wheat AI CM16 (36 %)         IGNE-DCTPWMSTLITPLPSCRDYVEQQACRI-ETPGS-------PYLAKQQCCGELANIPQ-QCRCQAL
Members without known inhibitory function
[54] Barley pUP23 (52 %)    AAATLGSVKD-ECQLGVDFPHNPLATCHTYVIKRVCGR----GPSRPM-----LVKERCCRELAAVPD-HCRCEAL
[55] Rice A17 (34 %)        DHHQVYSPGE-QCRPGISYPTYSLPQCRTLVR-RQC-V-G-RGAS- AADEQ-V-WQDCCRQLAAVDDGWCRCGAL
[56] Rice A5B (34 %)              TPAP-LCQPGMGYPMYPLPRCRALVK-RQC-V----GRGTAAAAEQVR-RD-CCRQLAAVDDSWCRCEAI
[57] Rice A14 (33 %)     DHHKDQVVYSLGE-RCQPGMGYPMYSLPRCR-AVVKRQC-V-GTR-SPG-AVDEQ-L-AQDCCRELAAVDDSWCRCSAL
[58] Barley pUP13 (33 %)         ERDYGEYCRVGKSIPINPLPACREYI-TRRCAV----GDQQV----PDVLKQQCCRELSDLPES-CRCDAL
[57] Rice AG2 (32 %)     DHHKDQVVYSLGE-RCQPGMGYPMYSLPRCR-AVVKRQC-V-G-HGAPGGAVDEQ-L-RQDCCRQLAAVDDSWCRCSAL
[57] Rice A5 (30 %)     EYHHQDQVVYTRA--RCQPGMGYPMYSLPRCR-ALVKRQC-----RGS--AAAAEQV--RRDCCRQLAAVDDSWCRCEAI
[56] Rice A16 (31 %)              TPGQ-LCQPGIGYPTYPLPRCRAFVK-RQC-V-----APGTLD-EQVR-RG-CCRQLAGIDSSWCRCDAL
[59] Barley pUP44 (22 %)          SGPWMWCDPEMGHKVSPLTRCRALVKLE-C-V----GNRV-----PEDVLRDCCQEVANISNEWCRCGDL
                                   H3   ß1      ß2                   H4
                                  ===== ^^^     ^^^            =======-=xxx
                                  61       70          80         90        100       110            120
                                  .        .           .....  .....          .  .....  .              .
[40] Ragi bifunctional inhibitor  RILMDGVVTSS--GQHEGRLLQD-LPGCPRQVQRAF-APKLVTEVECNLATIHG-G----PFCLSLLGAGE
Members known as trypsin inhibitor
[41] Maize TI (66 %)              SILMDGAIPPGPDAQLEGR-LED-LPGCPREVQRGF-AATLVTEAECNLATISG-V----AECPWILGGGTMPSK
[42] Rye TI (62 %)                RILMDGVVTQQ--GVFEGGYLKD-MPNCPRVTQRSY-AATLVAPQECNLPTIHG-S----PYCPTLQAG
[43] Barley TI/CMe (56 %)         RIIMQGVVTWQ--GAFEGAYFKD-SPNCPRERQTSY-AANLVTPQECNLGTIHG-S----AYCPELQPGYGVVL
α-Amylase inhibitors active as monomers
[44] Sorghum AI SIalpha4 (43 %)   GFMMDGVDAP----------LQD-FRGCTREMQRIYAVSRLTRAAECNLPTIPG-G----G-CHSLNSPR
[44] Sorghum AI SIalpha5 (41 %)   RTALDSMMTGY-EMR----------PTCSWGGLLTF-APTIVCYRECNLRTLHG-R----PFCYALGAEGTTT
[45] Barley CMa (41 %)            RYF------IGRRSHPDWSVLKD-LPGCPKEPQRDF-AKVLVTPGQCNVLTVHN-A----PYCLGLDI
[46] Wheat AI 0.19 (26 %)         YSMLDSMYKEH--GAQEGQAGTGAFPRCRREVVK-LTAA-SITAV-CRLPIVVDASGDGAYVCK-DVAAYPDA
[47] Wheat AI 0.28(26 %)          SSMLRSVAQEL--GVREGK---EVLPGCRKEVMK-LTAA-SVPEV-CKVPIPNP-SGDRAGVCYGDWAAYPDV
[48] Wheat AI 0.53 (25 %)         YSMLDSMYKEH--GVSEGQAGTGAFPSCRREVVK-LTAA-SITAV-CRLPIVVDASGDGAYVCK-DVAAYPDA
α-Amylase inhibitors active as heterooligomers
[49] Barley CMd (43 %)            RYFMALPVPSQPVD-X2-SGLMD-LPGCPREMQRDF-VRLLVAPGQCNLATIHNVR-----YCPAVEQPLWI
[50] Wheat CM2 (42 %)             RYF------IGRTSDPNSGVLKD-LPGCPREPQRDFA-KVLVTPGHCNVMTVHN-T----PYCLGLDI
[51] Wheat CM3 (41 %)             RYFIALPVPSQPVD-X4-SGLID-LPGCPREMQWDF-VRLLVAPGQCNLATIHNVR-----YCPAVEQPLWI
[51] Wheat CM1 (41 %)             RYF------IGRRSDPNSSVLKD-LPGCPREPQRDFA-KVLVTSGHCNVMTVHN-A----PYCLGLDI
[45] Barley CMb (39 %)            RFFM-G-----RKSRPDQSGLME-LPGCPREVQMDF-VRILVTPGFCNLTTVHN-T----PYCLAMDEWQWNRQFCSS
[52] Wheat AI CM17 (37 %)         RYFM-G-----PKSRPDQSGLME-LPGCPREVQMNF-VPILVTPGYCNLTTVHN-T----PYCLGMEESQWS
[53] Wheat AI CM16 (36 %)         RYFM-G-----PKSRPDQSGLME-LPGCPREVQMDF-VRILVTPGYCNLTTVHN-T----PYCLAMEESQWS
Members without known inhibitory function
[54] Barley pUP23 (52 %)          RILMDGVRTPE-GRVVEGR-LGD-RRDCPREEQRAF-AATLVTAAECNLSSVQAPG-----VRLVLLADG
[55] Rice A17 (34 %)              DHMLSGIYRELGATEAGHPMA-EVFPGCRRGDLERA-AASLPA--FCNVDIPNGPG----GVCYWLGYPRTPRTGH
[56] Rice A5B (34 %)              SHMLGGIYREL-GAPDVGHPMSEVFRGCRRGDLERA-AASLPA--FCNVDIPNGGG----GVCYWLARSGY
[57] Rice A14 (33 %)              NHMVGGIYRELGATDVGHPMA-EVFPGCRRGDLERA-AASLPA--FCNVDIPNGTG----GVCYWLGYPRTPRTGH
[58] Barley pUP13 (33 %)          SILVNGVITED--GSRVGR--MEAVPRCDGERIHSM-GSYLTAYSEQNPHNPGTPR----GDCV-LFGGGS
[57] Rice AG2 (32 %)              NHMVGGIYRELGATDVGHPMA-EVFPGCRRGDLERA-AASLPA--FCNVDIPNGTG----GVCYWLGYPRTPRTGH
[57] Rice A5 (30 %)               SHMLGGIYRELGAPDVGHPMS-EVFRGCRRGDLERA-AASLPA--FCNVDIPNGGG----GVCYWLARSGY
[56] Rice A16 (31 %)              NHMLRIIYREE-RAADAGHPMAEVFRGCRRGDIERA-AASLPA--FCNVDIPNGVG----GVCYWLPGTGY
[59] Barley pUP44 (22 %)          GSMLRSVYAAL--GVGGGPE--EVFPGCQKDVMKLLVA--GVPAL-CNVPIPNE-AAGTRGVCYWSASTDT
Abbreviations of insertions:
Barley CMd: X1 = EWMTSAELNYPGQ; X2 = PSTGNVGQ; Wheat CM3: X3 = EWMTSASIYSPGK; X4 = PRSGNVGE
Structure
An alignment of the RBI sequence [40] with known sequences of other
members of the cereal inhibitor superfamily [41–59]. The regular
secondary structures of RBI in the structure of the RBI–TMA complex
are indicated as follows: ===, α helices; ^^^, β strands; xxx,
310 helices. The number of sequences shown is limited to proteins
exhibiting significant sequence identity with RBI over the whole range
of the RBI sequence. The N termini of the mature proteins were either
determined by protein sequencing or deduced from the gene
sequence and the putative cleavage site for the signal peptidase.
N-terminal elongations, which are expected to weaken or abolish
binding to α-amylases, are shown in italics. Regions corresponding to
RBI’s binding segment 1 (residues 1–11 and 52–55) and binding
segment 2 (residues 61, 67–70, 72, 107–110 and 115–117) in the
RBI–TMA complex are on a gray background. Amino acid numbering is
according to RBI.
Consistency of the binding scheme with biochemical
experiments
Most α-amylase inhibition studies previously performed
with RBI and various other members of the cereal inhibitor
superfamily can be rationalized readily with the three-
dimensional model of the RBI–TMA complex. The direct
involvement of the three acidic active-site residues of
α-amylases in binding this class of inhibitors was demon-
strated with active-site mutants of Bacillus subtilis α-amylase.
This α-amylase is strongly inhibited by the wheat α-amylase
inhibitors 0.53 and 0.19 (cf. Figure 6), but replacement of
either active-site residue with the corresponding amide
sidechain resulted in a substantial decrease of binding
affinity [22]. The importance of the N-terminal inhibitor
segment for α-amylase binding was suggested by mutagen-
esis studies on the wheat α-amylase inhibitor (WAI) 0.28
(cf. Figure 6), for which N-terminal elongations or inser-
tions after residue 4 (corresponding to Thr4 in RBI) either
diminished or abolished inhibition of TMA [23]. In general,
elongations at the N terminus of RBI cannot be tolerated
sterically in the RBI–TMA complex without a complete
shift of the N-terminal segment along the substrate-binding
cleft of TMA. Insertion of 1–5 residues after residues 57
and 58 of WAI 0.28 (corresponding to Glu58 and Ala59 in
the third α helix of RBI) yielded an inactive inhibitor [23].
These insertions probably distort the region corresponding
to residues 52–55 in RBI’s binding segment 1 and abolish
α-amylase inhibition.
The chemical modification of the amino groups of RBI
with 2,4,6-trinitrobenzene-sulfonic acid and its tyrosines
with iodine diminishes inhibition of PPA [24,25]. Iodina-
tion probably modifies Tyr54 in binding segment 1 and a
RBI N terminus modified with a bulky trinitrophenyl group
is expected to severely affect binding by steric hindrance.
Unfortunately, the chemical modification data were misin-
terpreted and an inhibition mechanism similar to that of
tendamistat was proposed (see below), involving Trp22,
Tyr23 and Lys96 [25].
Sequence comparison of the a-amylase binding segments
of RBI with corresponding regions of other cereal inhibitors
The inhibitor WAI 0.19 is the only other member of the
cereal inhibitor superfamily whose three-dimensional
structure has been determined [18,26]. The X-ray struc-
ture of WAI 0.19 is very similar to that of RBI, supporting
the view that the folds of these cereal inhibitors are basi-
cally identical. At present, 26 primary structures of members
of the cereal inhibitor superfamily are known that share
22–66% sequence identity with RBI (Figure 6). Three
other members are trypsin inhibitors, 13 members are
α-amylase inhibitors, which act as monomers, homodimers
or hetero-oligomers, and nine members have no reported
inhibitory activity. Because α-amylase inhibition by RBI
primarily requires the arrow-head-like segment 1, we have
analyzed the sequences of the corresponding segments of
the other inhibitors in order to rationalize their inhibitory
activities against α-amylases. Strikingly, all three trypsin
inhibitors of the family have very similar primary struc-
tures compared to RBI, especially within the α-amylase
binding segments 1 and 2 (Figure 6). The N-terminal
serine, which lacks the reported sequence of the barley
trypsin inhibitor, is probably present in the protein because
a serine codon at this position is observed in the gene and
the reported N terminus only corresponds to the assumed
signal peptidase cleavage site. Thus, it appears likely that
these three proteins also inhibit α-amylases and, like RBI,
are bifunctional inhibitors. Indeed, an inhibitory activity
against insect α-amylases has been indicated for the maize
trypsin inhibitor [10].
It is interesting to note that within the α-amylase binding
segments 1 and 2 the α-amylase inhibitors of the cereal
inhibitor superfamily share even less sequence identity
with RBI than the trypsin inhibitors. There is also some
variability in the N-terminal residue, which may be serine,
theonine, valine or isoleucine (Figure 6). Although the
hydroxyl group of Ser1 is involved in three important
hydrogen bonds with TMA residues in the RBI–TMA
complex (Table 1), an N-terminal threonine should be
able to form the same interactions. Even an N-terminal
valine or isoleucine is not expected to affect binding steri-
cally to a large extent, and the lack of hydrogen bonds
might be compensated for by favorable hydrophobic inter-
actions with, for example, Tyr60 (TMA). The length of
the N-terminal segment corresponding to residues 1–6
in RBI varies between five and seven residues in the
α-amylase inhibitors. Only the α-amylase inhibitors CMd
from barley and SIalpha4 from sorghum display shorter
N-terminal sequences (four and three residues, respec-
tively). A shorter N-terminal sequence might be an adap-
tation to α-amylases from various sources, whereas elonga-
tion of the N terminus should severely affect inhibitory
activity ([23]; see above). Whether or not some of the
members for which no inhibitory function is known also
inhibit α-amylases remains to be established.
A comparison with other a-amylase–inhibitor complexes
Three structures of other complexes between an α-amylase
and a proteinaceous inhibitor have been reported: the
X-ray structures of the complexes between PPA and the
inhibitors tendamistat [15] and α-AI [16], and the complex
between barley α-amylase (BAA) and the barley α-amylase/
subtilisin inhibitor (BASI; [27]). A comparison of the
structures of the complexes shows that all these proteina-
ceous inhibitors are competitive and interact with similar
regions of the enzymes. RBI, tendamistat, α-AI and
BASI, however, are not related and bind to α-amylases in
entirely different ways.
In the tendamistat–PPA complex, the conserved tripep-
tide segment Trp18–Arg19–Trp20 of the inhibitor binds
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to the active site of PPA, where Arg19 (tendamistat) forms
a salt bridge with the catalytic Glu233 (PPA) and Tyr20
(tendamistat) is hydrogen bonded to Nε2 of His201 (PPA),
which contributes to calcium binding. In the α-AI–PPA
complex, two hairpin loops of α-AI (residues 29–46 and
171–189) lie completely in the active site. Hydrogen
bonds to Glu233 (PPA) and to one of the chloride-binding
residues, Asn298 (PPA), are formed by the hydroxyl group
of Tyr37 (α-AI), and to His201 (PPA) by Asp38 (α-AI).
Residues from α-AI’s second hairpin loop also target the
two other catalytic residues Asp197 and Asp300 (both
PPA). Tyr186 (α-AI) forms a hydrogen bond with Asp197
(PPA), whereas Asp300 (PPA) is interacting with the
hydroxyl groups of Ser189 and Tyr190 (both α-AI). In
contrast, all catalytic residues of the enzyme are directly
interacting through hydrogen bonds with the two N-ter-
minal inhibitor residues in the RBI–TMA complex (see
above), and there are no hydrogen bonds between RBI
residues and the calcium-binding and chloride-binding
TMA residues His189 (corresponding to His201 in PPA)
and Asn285 (corresponding to Asn298 in PPA; cf. Table 1).
Hydrophobic contacts between enzyme and inhibitor in
the three complexes RBI–TMA, tendamistat–PPA and
α-AI–PPA involve similar regions in the substrate-binding
grooves of TMA and PPA and confer further stability to
the complexes. In both the tendamistat–PPA and the
α-AI–PPA complex, hydrophobic interactions with residues
lining the active-site groove of PPA (Trp58, Trp59, Tyr62,
Tyr151 and Leu162) are observed. In the RBI–TMA
complex, the corresponding TMA residues (Trp56, Trp57,
Tyr60, Tyr139 and Leu150) undergo hydrophobic inter-
actions with RBI sidechains. Finally, a completely differ-
ent inhibition mode was observed for the BASI–BAA
complex in which BASI sterically blocks the active-site
cleft of BAA and a calcium ion, enclosed in the contact
area, interacts with the catalytic sidechains of BAA [27].
BASI, like RBI, is a bifunctional α-amylase–proteinase
inhibitor from plant seeds, but belongs to the STI–Kunitz
family [19] and does not exhibit sequence or structure
homology with RBI.
The interaction between RBI and PPA
RBI is also a potent inhibitor of PPA (Ki = 11 nM for PPA
isoform II; [17]), which shares 54% sequence identity
with TMA [1,2]. As a result of the high homology between
TMA and PPA, especially in the substrate-binding and
inhibitor-binding groove [1,2], it is very likely that RBI
basically binds in the same way to both α-amylases. TMA
is mainly distinguished from PPA by three truncations in
loop regions [1,2]. The longer loop segments in PPA are
involved in binding tendamistat [15] and α-AI [16]. The
glycine-rich loop of PPA (residues 304–310 in PPA) is
shorter by three residues in TMA; the other two loops
(corresponding to residues 140–148 and 342–361 in PPA)
are shorter by six and eight residues in TMA, respectively.
The additional loops present in PPA do not seem to be of
critical importance for binding these inhibitors, however,
because both tendamistat and α-AI inhibit mammalian
as well as insect α-amylases ([2,28]; G.W., unpublished
observations). Nevertheless, a modeled RBI–PPA complex
(Figure 7) suggests additional interactions between RBI
and PPA involving these three loops present in the mam-
malian α-amylase, but absent in TMA. Using the program
NACCESS [29], we calculated the water-accessible surface
areas of the RBI–TMA complex and the RBI–PPA complex,
as well as those of the uncomplexed proteins. After sub-
tracting the surface area of the complexes from the com-
bined surface areas of the single components, the resulting
solvent-excluded area was divided by two to yield a contact
area between the enzyme and the inhibitor of 1201 Å2 for
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Figure 7
A stereo view of the modeled structure of the
complex between porcine pancreatic
α-amylase (PPA; blue) and RBI (yellow) using
the coordinates of free PPA [14] and RBI in
the complex with TMA. Loops in the vicinity of
the active site, which are significantly longer in
PPA compared to TMA, are depicted in red
(residues 140–148; residues 304–310; and
residues 342–361). Only the polypeptide
backbones are shown. For modeling, the
same atoms as in Figure 2 were initially
superimposed. This figure was made with
MOLMOL [39].
the RBI–TMA complex, and 1436 Å2 for the RBI–PPA
model. The larger contact area may confer additional sta-
bility to the RBI–PPA complex. Preliminary inhibition
studies indicate that the affinity of RBI for TMA is indeed
approximately fivefold lower than that for PPA (S.S.,
unpublished observations). Thus, the loop deletions in the
insect enzyme might have evolved to protect TMA from
complete inhibition by proteinaceous α-amylase inhibitors
in the diet of the meal worm.
A model for the ternary complex between RBI, trypsin and
a-amylase
The surface-exposed trypsin-binding loop of RBI (resi-
dues Gly32–Pro33–Arg34–Leu35–Ala36–Thr37) is loca-
ted between α helices 1 and 2. In both the NMR
structure of free RBI and the X-ray structure of the RBI–
TMA complex, this loop possesses the so-called ‘canoni-
cal’ conformation [18], which is observed for many other
serine proteinase inhibitors and allows tight binding of
the inhibitors to the target proteases in a substrate-like
manner [19]. The RBI residues 32–37 in this canonical
loop are in an extended conformation, with the sidechain
of the P1 residue Arg34, which determines the specificity
for trypsin, projecting away from the scaffold towards the
solvent. Because the conformation of the loop generally
remains unaffected by binding of the target proteinase, a
reasonable model for the interaction between RBI and
trypsin can be obtained by a superimposition of RBI res-
idues 32–37 with the corresponding loop segments of
other trypsin inhibitors in complex with trypsin. To
model the structure of the ternary complex between
trypsin, RBI and TMA, we superimposed the X-ray struc-
tures of the RBI–TMA complex and the complex
between bovine pancreatic trypsin inhibitor (BPTI) and
trypsin [30] via the Cα atoms of RBI residues 33–35 and
the canonical loop residues of BPTI (14–16). Sub-
sequently, BPTI was removed and the contact area
between RBI and trypsin was energy minimized with
X-PLOR [31]. In the resulting model of the ternary
complex (Figure 8), TMA and trypsin are far apart so
that there is no steric clash that could prevent simultane-
ous binding of both target enzymes to RBI. The model
of the ternary complex is in full agreement with analyti-
cal gel-filtration experiments, which demonstrated a
stable ternary complex with a 1:1:1 stoichiometry, and
the fact that the inhibition constants of RBI for the target
enzymes are not affected in the ternary complex [17].
Biological implications
Organisms that live on a polysaccharide-rich diet depend
on the effectiveness of their carbohydrate processing
enzymes for survival. This is particularly true for insects
like the meal beetle Tenebrio molitor and its larvae, the
yellow meal worm. Both are cosmopolitan pests of seed
products. They have to circumvent the effects of inhibitors
that occur in their natural diet and target their digestive
enzymes. Plants, on the other hand, are compelled to
find new and better mechanisms of protecting their seeds
from numerous predatory organisms. The knowledge
about the mechanisms used by plants to inhibit the diges-
tive enzymes of insects is thus of predominant interest
for phytopharmacy.
The structure of yellow meal worm α-amylase (TMA) in
complex with RBI, the bifunctional α-amylase/trypsin
inhibitor from Indian finger millet (Ragi) revealed a
novel molecular mechanism of inhibition of α-amylases
from insect and mammalian sources by proteins from
cereals. In addition, the structure of the RBI–TMA
complex explains how RBI inhibits two unrelated diges-
tive enzymes from both insect and mammalian sources
simultaneously and independently. Apart from the general
interest in the inhibition of α-amylases, RBI and other
members of the cereal inhibitor superfamily, which are
widely distributed in common basic foodstuffs, might
present a valuable tool for protecting crop plants from
predatory insects via genetic engineering. Experiments
along this line have been initiated.
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Figure 8
A model of the structure of the ternary complex between trypsin, RBI
and TMA. The coloring is the same as in Figure 1, with trypsin
displayed in purple and its disulfide bridges rendered in yellow.
Modeling was based on the coordinates of the RBI–TMA complex and
trypsin in its complex with BPTI [30]. For modeling, the Cα atoms of
the P2, P1 and P1′ residues of RBI and BPTI were initially
superimposed. This figure was made with SETOR [37].
Materials and methods
Protein purification and crystallization
TMA and recombinant RBI were purified to homogeneity as described
previously [1,17,18]. Protein concentrations were determined by the spe-
cific absorbance at 280 nm (A280nm,1mg/ml,1cm = 1.64 for TMA and
0.680 for RBI). Prior to crystallization, concentrated solutions of the pro-
teins were mixed (RBI, 900 µl, 7.4 mg/ml, 0.56 mM; TMA, 450 µl,
30.9 mg/ml, 0.60 mM; both proteins in 20 mM acetic acid/NaOH,
pH 5.4, 100 mM NaCl, 1 mM CaCl2) were incubated for 30 min at room
temperature and subjected to size-exclusion chromatography on a
Superdex 200 HighLoad 26/60 column (Pharmacia), equilibrated with
5 mM sodium acetate (pH 5.4), 0.1 mM CaCl2, 100 mM NaCl. Fractions
containing the RBI–TMA complex were pooled and concentrated to
30 mg/ml. Crystals were grown at 4°C from 5µl droplets using the
hanging drop vapour diffusion method. The droplets consisted of equal
volumes of protein solution and precipitant (200 mM ammonium phos-
phate, 100 mM Tris–HCl (pH 8.5), 50% (w/v) 2-methyl-2,4-pentanediol)
and were equilibrated against 500µl of precipitant solution. The crystals
appeared after two weeks and grew to a maximum size of approximately
0.4 mm × 0.4 mm × 0.2 mm.
Data collection, structure solution and refinement
The crystals were directly mounted from the drop in thin-walled glass
capillaries. X-ray diffraction data were recorded at 4°C on an imaging
plate detector (MAR Research, Hamburg, Germany) attached to a
Rigaku-Denki rotating Cu-anode generator operated at 5.4 kW provid-
ing graphite-monochromatized CuKα radiation. Altogether, 78,106
reflections were collected (28,178 unique reflections with I > 3σ(I)).
Data were processed using the MOSFLM v. 5.23 program [32] and
routines from the CCP4 suite [33]. This resulted in an Rmerge of 0.093
(Rmerge = {ΣhΣj|I(h)j – 〈I(h)〉|}/{ΣhΣj|I(h)j|}) and an over-all completeness
(20.0–2.50 Å) of 97.3% and a completeness in the last shell (2.56–
2.50 Å) of 89.8%.
The three-dimensional structure was solved by two-body molecular
replacement using the coordinates of unliganded TMA [2] and those of
the NMR solution structure of RBI [18]. 20 solution structures (with all
non-glycine residues exchanged by alanines) were averaged, rendering
a searching model. Pseudo-temperature factors were calculated based
on the rmsd for each atom with the help of X-PLOR v. 3.1 [31]. The
program AMoRe [34] was applied for rotational and translational
searches, resulting in C2221 as the correct space group with cell con-
stants a = 79.16 Å, b = 186.87 Å and c = 111.54 Å, and one RBI–
TMA complex per asymmetric unit. After positional refinement by
means of X-PLOR [31] the calculated (2Fobs – Fcalc) and (Fobs – Fcalc)
electron density maps permitted modeling of the structural differences
as compared with the searching models. The modeling was performed
on a Silicon Graphics Workstation using the program TURBO-FRODO
[35]. Three cycles of manual rebuilding and least-squares reciprocal
space refinement (including positional and individual constrained tem-
perature factor refinement) with X-PLOR [31] finally resulted in a model
with a crystallographic R-factor of 19.1% (free R-factor 26.1%) as
refined against 26825 reflections between 7.0 Å and 2.5 Å resolution
after overall anisotropic temperature factor refinement using X-PLOR
[31]. The final model contains all 471 TMA residues and 117 RBI
residues. No electron density was observed for the last five RBI
residues. One calcium cation and one chloride anion were assigned at
positions homologous to those in unliganded TMA based on strong
electron density peaks. A patch residue with appropriate topology and
parameter values was set up for the N-terminal pyroglutamate of TMA
for refinement with X-PLOR. 331 water molecules were additionally
introduced at stereochemically reasonable positions.
Quality of the final model
The rmsd from standard values were determined to be 0.009 Å for
bond lengths and 1.563° for angles. The quality of the model was
assessed with the program PROCHECK [36]. A Ramachandran plot
[20] of the (φ/ψ)-angles indicates that 85% of the amino acids are in
the most favoured regions and 14% are in additionally allowed regions.
Met10 (RBI) is in the generously allowed region, and Ser12, Asp390
(both TMA) and Val2 (RBI) are localized in disallowed regions. All these
residues are well defined by electron density.
Accession numbers
The atomic coordinates of the complex have been deposited with the
Brookhaven Protein Data Bank, accession number 1TMQ, and will be
released with a delay of one year, but are available from the authors on
request in the meantime. 
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